Federal Register / Vol. 75, No. 200 / Monday, October 18, 2010 / Notices 63845 

infection control in ambulatory care 

settings. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Michelle King, HICPAC, Division of 

Healthcare Quality Promotion, CDC, 

l600 Clifton Road, NE., Mailstop A–07, 

Atlanta, Georgia 30333. Telephone (404) 

639–2936. E-mail: hicpac@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: October 8, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–26113 Filed 10–15–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; ITVA 

Conflicts & Eating Disorders. 

Date: November 10, 2010. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Francois Boller, MD, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6142, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1513, 

bollerf@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Services Conflicts. 

Date: November 12, 2010. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: October 8, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26161 Filed 10–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0389] 

Medical Device User Fees; Public 

Meeting; Extension of Comment Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; extension of comment 

period. 

SUMMARY: The Food and Drug 

Administration (FDA) is extending to 

November 1, 2010, the comment period 

for the notice that appeared in the 

Federal Register of August 13, 2010 (75 

FR 49502). In the notice, FDA requested 

input and comments from interested 

stakeholders on the Agency’s medical 

user fee program and requested 

suggestions regarding the commitments 

FDA should propose for the next 

reauthorized program. The Agency is 

taking this action to allow interested 

persons additional time to submit 

comments. 

DATES: Submit either electronic or 

written comments and information by 

November 1, 2010. 

ADDRESSES: Submit electronic 

comments to http:// 

www.regulations.gov. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. To ensure 

consideration, all comments must be 

received by November 1, 2010. Identify 

comments with the docket number 

found in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

James Swink, Center for Devices and 

Radiological Health, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 66, rm. 1609, Silver Spring, 

MD 20993–0002, 301–796–6313, FAX: 

301–847–8121, e-mail: 

James.Swink@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of August 13, 

2010 (75 FR 49502), FDA published a 

notice announcing a public meeting on 

September 14, 2010, and the opening of 

a public docket to seek input and 

comments from interested stakeholders 

to discuss the Agency’s medical user fee 

program and requested suggestions 

regarding the commitments FDA should 

propose for the next reauthorized 

program. Interested persons were 

invited to submit comments to the 

public docket by October 14, 2010. At 

this time, the Agency is announcing its 

intention to post the transcript of the 

September 14, 2010, public meeting and 

is extending the comment period until 

November 1, 2010, to continue to 

receive public comments. 

II. Request for Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) either electronic or written 

comments regarding this document. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Dated: October 14, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–26253 Filed 10–14–10; 4:15 pm] 

BILLING CODE 4160–01–P 

mstockstill on DSKH9S0YB1PROD with NOTICES